Research Portfolio

Exploring the Possibilities of Proton Therapy

At the University of Florida Health Proton Therapy Institute, confidence doesn't just come from the cancer treatments we provide to our patients every day. We draw confidence from the unexplored possibilities of cancer treatment. What's more, we work every day to expand the power of proton therapy – for today's patients, and tomorrow's.

UF Health Proton Therapy Institute published research

Comparsion Image - Proton Therapy is on the left, IMRT is on the right.

Publications 2006 – Present Last updated April 13, 2016

  1. Bryant CS, Smith TL, Henderson RH, Hoppe BS, Mendenhall WM, Nichols RC, Morris CG, Williams CR, Su Z, Li Z, Lee D, Mendenhall NP. Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life Following Delivery of Dose-Escalated Image-Guided Proton Therapy for Prostate Cancer. 2016 May;95(1):435-43. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2016.02.038. Epub 2016 Feb 16.
  2. Indelicato DJ, Rotondo RL, Begosh-Mayne D, Scarborough MT, Gibbs CP, Morris CG, Mendenhall WM. A Prospective Outcomes Study of Proton Therapy for Chordomas and Chondrosarcomas of the Spine. 2016 May; 95(1):297-303. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2016.01.057. Epub 2016 Feb 5.
  3. Dagan R, Bryant CS, Li Z, Yeung D, Justice J, Dzieglewiski P, Werning J, Fernandes R, Pirgousis P, Lanza DC, Morris CG, Mendenhall WM. Outcomes of Sinonasal Cancer Treated With Proton Therapy. 2016 May; 95(1):377-85. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2016.02.019. Epub 2016 Feb 11.
  4. Holtzman AL, Hoppe BS, Letter HP, Bryant CS, Nichols RC, Henderson RH, Mendenhall WM, Morris CG, Williams CR, Li Z, Mendenhall NP. Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound. 2016 May;95(1):465-71. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2015.12.351. Epub 2015 Dec 18.
  5. Hoppe BS, Henderson RH, Pham D, Cury JD, Bajwa A, Morris CG, D’Agostino H, Flampouri S, Huh S, Li Z, McCook B, Nichols RC. A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study. 2016 May;95(1):517-22. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2015.11.004. Epub 2015 Nov 8.
  6. Bradley JA, Dagan R, Ho MW, Rutenberg M, Morris CG, Li Z, Mendenhall NP. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons. Int J Radiat Oncol Biol Phys. 2016 May; Vol. 95(1):411-21. doi: 10.1016/j.ijrobp.2015.09.018. Epub 2015 Sep 25. pii: S0360-3016(15)03348-9. PubMed PMID: 26611875.
  7. Lee DT, Mendenhall NP, Smith TL, Morris CG, Nichols RC, Bryant CS, Henderson RH, Mendenhall WM, Costa J, Williams CR, Li Z, Hoppe BS. Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer. Int J Particle Ther. 2016 Apr;2(4):518-24.
  8. Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria®  Diffuse Large B-Cell Lymphoma. Am J Clin Oncol. 2015 Dec;38(6):610-20. doi: 10.1097/COC.0000000000000215. PubMed PMID: 26583344.
  9. Rotondo RL, Folkert W, Liebsch NJ, Chen YL, Pedlow FX, Schwab JH, Rosenberg AE, Nielsen GP, Szymonifka J, Ferreira AE, Hornicek FJ, Delaney TF. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine. 2015 Dec;23(6):788-97. doi: 10.3171/2015.3.SPINE14716. Epub 2015 Sep 4. PubMed PMID: 26340383.
  10. Vern-Gross TZ, Bradley JA, Rotondo RL, Indelicato DJ. Fertility in childhood cancer survivors following cranial irradiation for primary central nervous system and skull base tumors. Radiother Oncol. 2015 Nov;117(2):195-205. doi: 10.1016/j.radonc.2015.10.001. Epub 2015 Oct 20. Review. PubMed PMID: 26475251.
  11. Nichols RC, Huh S, Li Z, Rutenberg M. Proton therapy for pancreatic cancer. World J Gastrointest Oncol. 2015 Sep 15;7(9):141-7. doi: 10.4251/wjgo.v7.i9.141. Review. PubMed PMID: 26380057; PubMed Central PMCID: PMC4569591.
  12. Uh J, Merchant TE, Li Y, Li X, Sabin ND, Indelicato DJ, Ogg RJ, Boop FA, Jane JA Jr, Hua C. Effects of Surgery and Proton Therapy on Cerebral White Matter of Craniopharyngioma Patients. Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):64-71. doi: 10.1016/j.ijrobp.2015.05.017. Epub 2015 May 16. PubMed PMID: 26279025.
  13. Sachsman S, Flampouri S, Li Z, Lynch J, Mendenhall NP, Hoppe BS. Proton therapy in the management of non-Hodgkin lymphoma. Leuk Lymphoma. 2015 Sep;56(9):2608-12. doi: 10.3109/10428194.2015.1014364. Epub 2015 May 18. PubMed PMID: 25669925.
  14. Hua C, Shulkin BL, Indelicato DJ, Li Y, Li X, Boop FA, Merchant TE. Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma. J Neurosurg Pediatr. 2015 Aug 21:1-7. PubMed PMID: 26295365.
  15. Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RL, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1053-9. doi: 10.1016/j.ijrobp.2015.04.039. Epub 2015 May 1. PubMed PMID:  26194680; PubMed Central PMCID: PMC4684186.
  16. Sachsman S, Hoppe BS, Mendenhall NP, Holtzman A, Li Z, Slayton W, Joyce M, Sandler E, Flampouri S. Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma. Leuk Lymphoma. 2015 Jul;56(7):2019-24. doi: 10.3109/10428194.2014.975802. Epub 2014 Nov 19. PubMed PMID: 25315071.
  17. Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O'Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):602-612. doi: 10.1016/j.ijrobp.2015.02.013. Review. PubMed PMID: 26068493.
  18. Kole TP, Nichols RC, Lei S, Wu B, Huh SN, Morris CG, Lee S, Tong M, Mendenhall NP, Dritschilo A, Collins SP. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. Acta Oncol. 2015 Jun;54(6):825-31. doi: 10.3109/0284186X.2014.953260. Epub 2014 Sep 17. PubMed PMID: 25227898.
  19. Zeitlin R, McPhillips M, Harris S, Mandia S, Williams CR, Costa J, Morris CG, Su Z, Li Z, Mendenhall NP. Fiducial Markers, Saline, and Balloons to Locate and Stabilize the Prostate during Proton Therapy. Int J Particle Ther. 2015 Jun;2(1)29-36.
  20. Slopsema R, Mamalui M, Rutenberg M, Yeung D, Li Z, Bolling J, Flampouri S, Dagan R. TH-CD-BRA-01: The Benefit of Adjunct CT Imaging in Clip-Based Treatment of Ocular Melanoma with Protons. Med Phys. 2015 Jun;42(6):3725. doi: 10.1118/1.4926217. PubMed PMID: 26129517.
  21. Su Z, Dagan R, Li Z. SU-E-T-686: SBRT 4-Dimensional Treatment Planning for Vero Dynamic Tumor Tracking Lung Patients. Med Phys. 2015 Jun;42(6):3494. doi: 10.1118/1.4925049. PubMed PMID: 26128351.
  22. Flampouri S, Li Z, Hoppe B. SU-E-T-622: Planning Technique for Passively-Scattered Involved-Node Proton Therapy of Mediastinal Lymphoma with Consideration of Cardiac Motion. Med Phys. 2015 Jun;42(6):3479. doi: 10.1118/1.4924985. PubMed PMID: 26128284.
  23. Kryck E, Mamalui-Hunter M, Li Z, Slopsema R. SU-E-T-03: 3 Year Clinical Experience with the IBA Proton Eyeline. Med Phys. 2015 Jun;42(6):3331. doi: 10.1118/1.4924364. PubMed PMID: 26127670.
  24. Pirlepesov F, Shin J, Moskvin VP, Gray J, Li Z, Hua C, Gajjar A, Krasin MJ, Merchant TE, Farr JB. SU-F-BRD-14: Dose Weighted Linear Energy Transfer Analysis  of Critical Structures in Proton Therapy of Pediatric Brain Tumor Patients. Med Phys. 2015 Jun;42(6):3528. doi: 10.1118/1.4925193. PubMed PMID: 26128490.
  25. Petroccia H, Li Z, Mendenhall N, Bolch W. SU-E-T-559: Monte Carlo Simulation of Cobalt-60 Teletherapy Unit Modeling In-Field and Out-Of-Field Doses for Applications in Computational Radiation Dosimetry. Med Phys. 2015 Jun;42(6):3464. doi: 10.1118/1.4924921. PubMed PMID: 26128224.
  26. Mendenhall WM, Henderson RH, Costa JA, Hoppe BS, Dagan R, Bryant CM, Nichols RC, Williams CR, Harris SE, Mendenhall NP. Hemorrhagic Radiation Cystitis. Am J Clin Oncol. 2015 Jun;38(3):331-6. PubMed PMID: 24322335.
  27. Hoppe BS, Hoppe RT. Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):40-5. doi: 10.1016/j.ijrobp.2015.02.008. PubMed PMID: 25863752.
  28. Hoppe BS, Bryant C, Sandler HM. Radiation for prostate cancer: intensity modulated radiation therapy versus proton beam. J Urol. 2015 Apr;193(4):1089-91. doi: 10.1016/j.juro.2015.01.069. Epub 2015 Jan 15. PubMed PMID: 25598137.
  29. Yeung D, Boes P, Ho MW, Li Z. A Web application for the management of clinical workflow in image-guided and adaptive proton therapy for prostate cancer treatments. J Appl Clin Med Phys. 2015 May 8;16(3):5503. doi: 10.1120/jacmp.v16i3.5503. PubMed PMID: 26103504.
  30. Colaco RJ, Hoppe BS, Flampouri S, McKibben BT, Henderson RH, Bryant C, Nichols RC, Mendenhall WM, Li Z, Su Z, Morris CG, Mendenhall NP. Rectal Toxicity After Proton Therapy For Prostate Cancer: An Analysis of Outcomes of Prospective Studies Conducted at the University of Florida Proton Therapy Institute. Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):172-81. doi: 10.1016/j.ijrobp.2014.08.353. Epub 2014 Nov 5. PubMed PMID: 25442338.
  31. Sachsman S, Nichols RC, Morris CG, Zaiden R, Johnson EA, Awad Z, Bose D, Ho MW, Huh SN, Li Z, Kelly P, Hoppe BS. Proton Therapy and Concomitant Capecitabine for Non-Metastatic Unresectable Pancreatic Adenocarcinoma. Int J Particle Ther. 2014;1(3):692–701.
  32. Mendenhall WM, Costa JA, Williams CR, Harris SE, Mandia SE, Hoppe BS, Henderson RH, Bryant CM, Nichols RC, Mendenhall NP. Bacterial Urinary Tract Infection after Fiducial Marker Placement or Prostate Biopsy. Int J Particle Ther. 2014;1(3):745–758.
  33. Cooper SL, Rotondo R, Bradley J, Cox R, Indelicato DJ. Proton therapy for radiation-induced parameningeal rhabdomyosarcoma. Appl Radiat Oncol. 2014 Dec;3(4):14-8.
  34. Xu N, Ho MW, Li Z, Morris CG, Mendenhall NP. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease? Am J Clin Oncol. 2014 Dec;37(6):568-74. doi: 10.1097/COC.0b013e318280d614. PubMed PMID: 23466577.
  35. Ho CK, Flampouri S, Hoppe BS. Proton therapy in the management of lymphoma. Cancer J. 2014 Nov-Dec;20(6):387-92. doi: 10.1097/PPO.0000000000000076. PubMed PMID: 25415683.
  36. Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR appropriateness criteria follow-up of Hodgkin lymphoma. J Am Coll Radiol. 2014 Nov;11(11):1026-1033.e3. doi: 10.1016/j.jacr.2014.07.038. Epub 2014 Sep 30. PubMed PMID: 25278496.
  37. Indelicato DJ, Flampouri S, Rotondo RL, Bradley JA, Morris CG, Aldana PR, Sandler E, Mendenhall NP. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol. 2014 Oct;53(10):1298-304. doi: 10.3109/0284186X.2014.957414. Epub 2014 Oct 3. PubMed PMID: 25279957.
  38. Chen H, Matysiak W, Flampouri S, Slopsema R, Li Z. Dosimetric evaluation of hybrid brass/stainless-steel apertures for proton therapy. Phys Med Biol. 2014 Sep 7;59(17):5043-60. doi: 10.1088/0031-9155/59/17/5043. Epub 2014 Aug 13. PubMed PMID: 25119333.
  39. Christopherson KM, Bradley JA, Rotondo RL, Pincus DW, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ. Local control in non-metastatic medulloblastoma. Acta Oncol. 2014 Sep;53(9):1151-7. doi: 10.3109/0284186X.2014.932434. Epub 2014 Jul 3. PubMed PMID: 24991891.
  40. Holtzman A, Hoppe BS, Li Z, Su Z, Slayton WB, Ozdemir S, Joyce M, Sandler E, Mendenhall NP, Flampouri S. Advancing the Therapeutic Index in Stage III/IV Pediatric Hodgkin Lymphoma with Proton Therapy. Int J Particle Ther. 2014;1(2):343–356.
  41. Chang AL, Yock TI, Mahajan A, Hill-Kaiser C, Keole S, Loredo L, Cahlon O, McMullen KP, Hartsell W, Indelicato DJ. Pediatric Proton Therapy: Patterns of Care across the United States. Int J Particle Ther. 2014;1(2):357-67.
  42. Bradley JA, Indelicato DJ. Craniopharyngioma and Proton Therapy. Int J Particle Ther. 2014;1(2):386–398.
  43. Mendenhall WM, McKibben BT, Happe BS, Nichols RC, Henderson RH, Mendenhall NP. Management of Radiation Proctitis. Am J Clin Oncol. 2014 Oct;37(5):517-23. PubMed PMID: 23241500.
  44. Rutenberg MS, Flampouri S, Hoppe BS. Proton therapy for Hodgkin lymphoma. Curr Hematol Malig Rep. 2014 Sep;9(3):203-11. doi: 10.1007/s11899-014-0212-7. PubMed PMID: 24842407.
  45. Slopsema RL, Lin L, Flampouri S, Yeung D, Li Z, McDonough JE, Palta J. Development of a golden beam data set for the commissioning of a proton double-scattering system in a pencil-beam dose calculation algorithm. Med Phys. 2014 Sep;41(9):091710. doi: 10.1118/1.4893281. PubMed PMID: 25186385.
  46. Mendenhall WM, Henderson RH, Hoppe BS, Nichols RC, Mendenhall NP. Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy. Am J Clin Oncol. 2014 Aug;37(4):411-6.  PubMed PMID: 22772432.
  47. Flampouri S, Hoppe BS, Slopsema RL, Li Z. Beam-specific planning volumes for scattered-proton lung radiotherapy. Phys Med Biol. 2014 Aug 21;59(16):4549-66. doi: 10.1088/0031-9155/59/16/4549. Epub 2014 Jul 28. PubMed PMID: 25069103.
  48. Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, Dang NH, Lynch JW, Li Z, Morris CG, Mendenhall NP. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1053-9. doi: 10.1016/j.ijrobp.2014.04.029. Epub 2014 Jun 10. PubMed PMID: 24928256.
  49. Kil WJ, Mendenhall NP, Morris CG, Nichols RC, Henderson RH, Mendenhall WM, Bryant C, Williams C, Li Z, Hoppe BS. Patient-reported Hip Symptoms following Treatment with Proton Therapy for Prostate Cancer. Int J Particle Ther. 2014 Apr;1(1):14-21.
  50. Beltran C, Jia Y, Slopsema R, Yeung D, Li Z. A simplified methodology to produce Monte Carlo dose distributions in proton therapy. J Appl Clin Med Phys. 2014 Jul 8;15(4):4413. doi: 10.1120/jacmp.v15i4.4413. PubMed PMID: 25207391.
  51. Bryant C, Mendenhall NP, Henderson RH, Nichols RC, Mendenhall WM, Morris CG, Williams C, Su Z, Li Z, Hoppe BS. Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer? Am J Clin Oncol. 2014 Jul 2. [Epub ahead of print] PubMed PMID: 24710124.
  52. Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS. ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer. 2014 Jul;61(7):1305-12. doi: 10.1002/pbc.24983. Epub 2014 Feb 24. Review. PubMed PMID: 24616347.
  53. Christopherson KM, Rotondo RL, Bradley JA, Pincus DW, Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ. Late toxicity following craniospinal radiation for early-stage medulloblastoma. Acta Oncol. 2014 Apr;53(4):471-80. doi: 10.3109/0284186X.2013.862596. Epub 2014 Feb 24. PubMed PMID: 24564687.
  54. Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Mendenhall WM, Williams CR, Regan MM, Chipman JJ, Crociani CM, Sandler HM, Sanda MG, Hamstra DA. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 2014 Apr 1;120(7):1076-82. doi: 10.1002/cncr.28536. Epub 2013 Dec 30. PubMed PMID: 24382757; PubMed Central PMCID: PMC4103169.
  55. Sreeraman R, Indelicato DJ. Proton therapy for the treatment of children with CNS malignancies. CNS Oncol. 2014 Mar;3(2):149-58. doi: 10.2217/cns.14.16. PubMed PMID: 25055020.
  56. Mendenhall NP, Hoppe BS, Nichols RC, Mendenhall WM, Morris CG, Li Z, Su Z, Williams CR, Costa J, Henderson RH. Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):596-602. doi: 10.1016/j.ijrobp.2013.11.007. PubMed PMID: 24521677.
  57. Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS. ACR appropriateness Criteria® pediatric Hodgkin lymphoma. Pediatr Blood Cancer. 2014  Jul;61(7):1305-12. doi: 10.1002/pbc.24983. Epub 2014 Feb 24. PubMed PMID: 24616347.
  58. Colaco RJ, Nichols RC, Huh S, Getman N, Ho MW, Li Z, Morris CG, Mendenhall WM, Mendenhall NP, Hoppe BS. Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer. J Gastrointest Oncol. 2014 Feb;5(1):3-8. doi: 10.3978/j.issn.2078-6891.2013.041. PubMed PMID: 24490037; PubMed Central PMCID: PMC3904024.
  59. Yeung D, McKenzie C, Indelicato DJ. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study. Pediatr Blood Cancer. 2014 Jan;61(1):89-94. doi: 10.1002/pbc.24593. Epub 2013 Sep 2. PubMed PMID: 24000229.
  60. Nichols RC Jr, Hoppe BS. RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only). J Gastrointest Oncol. 2013 Dec;4(4):E33-4. doi: 10.3978/j.issn.2078-6891.2013.048. PubMed PMID: 24294518; PubMed Central PMCID: PMC3819775.
  61. Deraniyagala RL, Yeung D, Mendenhall WM, Li Z, Morris CG, Mendenhall NP, Okunieff P, Malyapa RS. Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute. J Neurol Surg B Skull Base. 2014 Feb;75(1):53-7. doi: 10.1055/s-0033-1354579. Epub 2013 Sep 9. PubMed PMID: 24498590; PubMed Central PMCID: PMC3912148. 
  62. Lee RY, Nichols RC Jr, Huh SN, Ho MW, Li Z, Zaiden R, Awad ZT, Ahmed B, Hoppe BS. Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers. J Gastrointest Oncol. 2013 Dec;4(4):374-9. doi: 10.3978/j.issn.2078-6891.2013.043. PubMed PMID: 24294509; PubMed Central PMCID: PMC3819780.
  63. Mendenhall WM, Hoppe BS, Nichols RC, Henderson RH, Mendenhall NP. When Is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer? Am J Clin Oncol. 2013 Dec;36(6):644-7. PubMed PMID: 22237149.
  64. Mendenhall WM, Henderson RH, Hoppe BS, Nichols RC, Mendenhall NP. Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer. Am J Clin Oncol. 2013 Oct;36(5):530-4. PubMed PMID: 21694574.
  65. Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology (Williston Park). 2013 Aug;27(8):786-94. PubMed PMID: 24133827.
  66. Figura N, Hoppe BS, Flampouri S, Su Z, Osian O, Monroe A, Nichols RC. Postoperative proton therapy in the management of stage III thymoma. J Thorac Oncol. 2013 May;8(5):e38-40.
  67. Shi W, Nichols Jr RC, Flampouri S, Li Z, His W, Huh S, Ho MW, Henderson RH, Mendenhall NP, Hoppe BS. Proton-Based Chemoradiation for Synchronous Bilateral Non-Small-Cell Lung Cancers: A Case Report. Thoracic Cancer. 2013 May;4(2):198-202.
  68. Brower JV, Indelicato DJ, Aldana PR, Sandler E, Rotondo R, Mendenhall NP, Marcus RB, Su Z. A Treatment Planning Comparison of Highly Conformal Radiation Therapy for Pediatric Low-Grade Brainstem Gliomas. Acta Oncol. 2013 Apr;52(3): 594-599.
  69. Kil WJ, Nichols RC Jr, Hoppe BS, Morris CG, Marcus RB Jr, Mendenhall WM, Mendenhall NP, Li Z, Costa JA, Williams CR, Henderson RH. Hypofractionated Passively Scattered Proton Radiotherapy for Low- and Intermediate-Risk Prostate Cancer Is Not Associated with Post-Treatment Testosterone Suppression. Acta Oncol. 2013 Apr;52(3): 492–497.
  70. Nichols RC Jr, George TJ, Zaiden RA Jr, Awad ZT, Asbun HJ, Huh S, Ho MW, Mendenhall NP, Morris CG, Hoppe BS. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol. 2013 Apr;52(3):498-505.
  71. Colaco RJ, Huh S, Nichols RC, Morris CG, D'Agostino H, Flampouri S, Li Z, Pham DC, Bajwa AA, Hoppe BS. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Acta Oncol. 2013 Apr;52(3):506-13.
  72. Holtzman A, Li Z, Flampouri S, Slayton W, Sandler E, Mendenhall NP, Hoppe B. Advancing the Therapeutic Index of Pediatric Patients with Stage III Hodgkin Lymphoma with Proton Therapy. Acta Oncol. 2013 Apr;52(3): 592-594.
  73. Holtzman A, Flampouri S, Li Z, Mendenhall NP, Hoppe BS. Proton therapy in a pediatric patient with stage III Hodgkin lymphoma. Acta Oncol. 2013 Apr;52(3):592-4. doi: 10.3109/0284186X.2013.765966. PubMed PMID: 23477362.
  74. Henderson RH, Hoppe BS, Marcus RB Jr, Mendenhall WM, Nichols RC Jr, Li Z, Su Z, Morris CG, Williams CR, Costa J, Mendenhall NP. Urinary Functional Outcomes and Toxicity Five Years after Proton Therapy for Low- and Intermediate-risk Prostate Cancer: Results of Two Prospective Trials. Acta Oncol. 2013 Apr;52(3): 463–469.
  75. Valery R, Mendenhall NP, Nichols RD Jr, Henderson R, Morris CG, Su Z, Mendenhall WM, Williams CR, Li Z, Hoppe BS. Hip Fractures and Pain following Proton Therapy for Management of Prostate Cancer. Acta Oncol. 2013 Apr;52(3): 486-491.
  76. Sabin ND, Merchant TE, Harreld JH, Patay Z, Klimo P Jr, Qaddoumi I, Armstrong GT, Wright K, Gray J, Indelicato DJ, Gajjar A. Imaging Changes in Very Young Children with Brain Tumors Treated with Proton Therapy and Chemotherapy. AJNR Am J Neuroradiol. 2013 Feb;34(2):446-50. PubMed PMID: 22821924.
  77. Hoppe BS, Mamalui-Hunter M, Mendenhall NP, Li Z, Indelicato DJ. Improving the Therapeutic Ratio by Using Proton Therapy in Patients With Stage I or II Seminoma. Am J Clin Oncol. 2013 Feb;36(1):31-7. PubMed PMID: 22134517.
  78. Kil WJ, Nichols RC Jr, Kilkenny JW, Huh SY, Ho MW, Gupta P, Marcus RB, Indelicato DJ. Proton Therapy versus Photon Radiation Therapy for the Management of a Recurrent Desmoid Tumor of the Right Flank: a case report. Radiat Oncol. 2012 Oct 26;7(1):178. PubMed PMID: 23098082.
  79. Jia Y, Beltran C, Indelicato DJ, Flampouri S, Li Z, Merchant TE. Proton therapy dose distribution comparison between Monte Carlo and a treatment planning system for pediatric patients with ependymoma. Med Phys. 2012 Aug;39(8):4742-7. doi: 10.1118/1.4736413. PubMed PMID: 22894399.
  80. Swanson EL, Indelicato DJ, Louis D, Flampouri S, Li Z, Morris CG, Paryani N, Slopsema R. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1549-57. doi: 10.1016/j.ijrobp.2011.10.014. Epub 2012 Jan 21. PubMed PMID: 22270176.
  81. McGee L, Mendenhall NP, Henderson RH, Morris CG, Nichols RC Jr, Marcus RJ Jr, Li Z, Mendenhall WM, Williams CR, Hoppe BS. Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer. Acta Oncol. 2013 Apr;52(3): 470-476.
  82. Su Z, Zhao T, Li Z, Hoppe B, Henderson R, Mendenhall W, Nichols RC, Marcus R, Mendenhall N. Reduction of prostate intrafraction motion using gas-release rectal balloons. Med Phys. 2012 Oct;39(10):5869-73. doi: 10.1118/1.4749932. PubMed PMID: 23039625.
  83. Lopatiuk-Tirpak O, Su Z, Li Z, Zeidan OA, Meeks SL, Maryanski MJ. Direct response to proton beam linear energy transfer (LET) in a novel polymer gel dosimeter formulation. Technol Cancer Res Treat. 2012 Oct;11(5):441-5. Epub 2012 May 7. PubMed PMID: 22568627.
  84. Hoppe BS, Flampouri S, Henderson RH, Pham D, Bajwa AA, D'Agostino H, Huh SN, Li Z, Mendenhall NP, Nichols RC. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results. Clin Lung Cancer. 2012 Sep;13(5):352-8. doi: 10.1016/j.cllc.2011.11.008. Epub 2012 Jan 20. PubMed PMID: 22264659.
  85. Hoppe BS, Nichols RC, Henderson RH, Morris CG, Williams CR, Costa J, Marcus RB Jr, Mendenhall WM, Li Z, Mendenhall NP. Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer. 2012 Sep 15;118(18):4619-26. doi: 10.1002/cncr.27398. Epub 2012 Jan 17. PubMed PMID: 22253020; PubMed Central PMCID: PMC3465790.
  86. Nichols RC Jr, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li Z, Regine WF. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):158-63. doi: 10.1016/j.ijrobp.2011.05.045. Epub 2012 Jan 13. PubMed PMID: 22245197.
  87. Mendenhall NP, Schild S, Slater J. Radiation therapy modalities for prostate cancer. JAMA. 2012 Aug 1;308(5):450-1; author reply 451-2. doi: 10.1001/jama.2012.8112. PubMed PMID: 22851100.
  88. Hoppe BS, Flampouri S, Lynch J, Slayton W, Zaiden R, Li Z, Mendenhall NP. Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy. Oncology (Williston Park). 2012 May;26(5):456-9, 462-5. Review. PubMed PMID: 22730602.
  89. Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):449-55. doi: 10.1016/j.ijrobp.2011.12.034. Epub 2012 Mar 2. PubMed PMID: 22386373.
  90. Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):260-7. doi: 10.1016/j.ijrobp.2011.06.1959. Epub 2011 Oct 17. PubMed PMID: 22014950.
  91. Williams C, Costa J, Mandia S, Henderson R, Marino R, Mendenhall N. Urethral catheterization facilitates preradiation fiducial marker placement in postprostatectomy patients. J Endourol. 2012 May;26(5):467-8. Epub 2012 Feb 3. PubMed PMID: 22141439.
  92. Nichols RC Jr, Morris CG, Hoppe BS, Henderson RH, Marcus RB Jr, Mendenhall WM, Li Z, Williams CR, Costa JA, Mendenhall NP. Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1222-6. Epub 2011 May 11. PubMed PMID: 21570206.
  93. Su Z, Lopatiuk-Tirpak O, Zeidan O, Sruprisan SI, Meeks SL, Slopsema R, Flampouri S, Li Z. An experimental investigation into the effect of periodic motion on proton dosimetry using polymer gel dosimeters and a programmable motion platform. Phys Med Biol. 2012 Feb 7;57(3):649-63. Epub 2012 Jan 12. PubMed PMID: 22241573.
  94. Dallas J, Imanirad I, Rajani R, Dagan R, Subbiah S, Gaa R, Dwarica WA, Ivey AM, Zlotecki RA, Malyapa R, Indelicato DJ, Scarborough MT, Reith JD, Gibbs CP, Dang LH. Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report. J Med Case Rep. 2012 Jan 30;6:41. PubMed PMID: 22289277; PubMed Central PMCID: PMC3277477.
  95. Mendenhall NP, Li Z, Hoppe BS, Marcus RB Jr, Mendenhall WM, Nichols RC, Morris CG, Williams CR, Costa J, Henderson R. Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):213-21. Epub 2010 Nov 17. PubMed PMID: 21093164.
  96. Su Z, Zhang L, Murphy M, Williamson J. Analysis of prostate patient setup and tracking data: potential intervention strategies. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):880-7. Epub 2010 Oct 8. PubMed PMID: 20934274; PubMed Central PMCID: PMC3020989.
  97. Mendenhall NP, Malyapa RS, Su Z, Yeung D, Mendenhall WM, Li Z. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol. 2011 Aug;50(6):763-71. Review. PubMed PMID: 21767172.
  98. Nichols RC, Huh SN, Henderson RH, Mendenhall NP, Flampouri S, Li Z, D'Agostino HJ, Cury JD, Pham DC, Hoppe BS. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study. Clin Lung Cancer. 2011 Jul;12(4):252-7. doi: 10.1016/j.cllc.2011.03.027. Epub 2011 Apr 27. PubMed PMID: 21726825.
  99. Hoppe B, Henderson R, Mendenhall WM, Nichols RC, Li Z, Mendenhall NP. Proton therapy for prostate cancer. Oncology (Williston Park). 2011 Jun;25(7):644-50, 652. Review. PubMed PMID: 21888265.
  100. Su Z, Zhang L, Ramakrishnan V, Hagan M, Anscher M. Investigations of interference between electromagnetic transponders and wireless MOSFET dosimeters: a phantom study. Med Phys. 2011 May;38(5):2450-4. PubMed PMID: 21776780; PubMed Central PMCID: PMC3188601.
  101. Jin H, Hsi W, Yeung D, Li Z, Mendenhall NP, Marcus RB Jr. Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams. J Appl Clin Med Phys. 2011 Jan 19;12(2):3308. PubMed PMID: 21587172.
  102. Hoppe BS, Huh S, Flampouri S, Nichols RC, Oliver KR, Morris CG, Mendenhall NP, Li Z. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. Radiother Oncol. 2010 Dec;97(3):425-30. Epub 2010 Oct 9. PubMed PMID: 20934768.
  103. Mendenhall WM, Nichols RC, Henderson R, Mendenhall NP. Is radical prostatectomy the "gold standard" for localized prostate cancer? Am J Clin Oncol. 2010 Oct;33(5):511-5. Review. PubMed PMID: 20010078.
  104. Hoppe BS, Flampouri S, Li Z, Mendenhall NP. Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma. Leuk Lymphoma. 2010 Aug;51(8):1559-62. PubMed PMID: 20578823.
  105. Aldana PR, MacGregor TL, James HE, Marcus RB Jr, Indelicato DJ. Titanium screws as fiducial markers for image-guided stereotactic proton irradiation in pediatric central nervous system tumors: a technical report. Pediatr Neurosurg. 2010;46(3):227-31. Epub 2010 Nov 4. PubMed PMID: 21051922.
  106. Chera BS, Vargas C, Morris CG, Louis D, Flampouri S, Yeung D, Duvvuri S, Li Z, Mendenhall NP. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):994-1002. Epub 2009 Jul 18. PubMed PMID: 19619961.
  107. Mendenhall WM, Henderson RH, Nichols RC, Keole SR, Mendenhall NP. Postprostatectomy radiotherapy for prostate cancer. Am J Clin Oncol. 2009 Oct;32(5):529-34. doi: 10.1097/COC.0b013e31817e6ef9. PubMed PMID: 19652581.
  108. Newlin HE, Indelicato DJ, Abbitt P, Marshall J, Wymer D, Grobmyer S, Haigh L, Copeland E, Morris CG, Mendenhall NP. Does surgical closure technique affect early mammographic detection of tumor recurrence after breast-conserving therapy? Am J Clin Oncol. 2009 Oct;32(5):499-503. doi: 10.1097/COC.0b013e318194f431. PubMed PMID: 19528792.
  109. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. Epub 2009 Apr 20. PubMed PMID: 19386423.
  110. Hsi WC, Indelicato DJ, Vargas C, Duvvuri S, Li Z, Palta J. In vivo verification of proton beam path by using post-treatment PET/CT imaging. Med Phys. 2009 Sep;36(9):4136-46. PubMed PMID: 19810487.
  111. Mendenhall WM, Henderson RH, Indelicato DJ, Keole SR, Mendenhall NP. Erectile dysfunction after radiotherapy for prostate cancer. Am J Clin Oncol. 2009 Aug;32(4):443-7. Review. PubMed PMID: 19657239.
  112. Chera BS, Malyapa R, Louis D, Mendenhall WM, Li Z, Lanza DC, Yeung D, Mendenhall NP. Proton therapy for maxillary sinus carcinoma. Am J Clin Oncol. 2009 Jun;32(3):296-303. PubMed PMID: 19433966.
  113. Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Oncol. 2009 Apr;32(2):180-6. PubMed PMID: 19307953.
  114. Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1426-33. Epub 2008 Aug 30. PubMed PMID: 18762391.
  115. Lin L, Vargas C, Hsi W, Indelicato D, Slopsema R, Li Z, Yeung D, Horne D, Palta J. Dosimetric uncertainty in prostate cancer proton radiotherapy. Med Phys. 2008 Nov;35(11):4800-7. PubMed PMID: 19070212.
  116. Vargas C, Wagner M, Indelicato D, Fryer A, Horne D, Chellini A, McKenzie C, Lawlor P, Mahajan C, Li Z, Lin L, Keole S. Image guidance based on prostate position for prostate cancer proton therapy. Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1322-8. Epub 2008 May 28. PubMed PMID: 18472365.
  117. Chvetsov AV, Palta JJ, Nagata Y. Time-dependent cell disintegration kinetics in lung tumors after irradiation. Phys Med Biol. 2008 May 7;53(9):2413-23. Epub 2008 Apr 17. PubMed PMID: 18421118.
  118. Vargas C, Wagner M, Mahajan C, Indelicato D, Fryer A, Falchook A, Horne D, Chellini A, McKenzie C, Lawlor P, Li Z, Lin L, Keole S. Proton therapy coverage for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1492-501. PubMed PMID: 18374228.
  119. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):744-51. Epub 2007 Sep 27. PubMed PMID: 17904306.
  120. Nichols Jr. RC, Henderson RH, Huh S, Flampouri S, Li Z, Bajwa AA, D'Agostino HJ, Pham DC, Mendenhall NP, Hoppe BS. Proton therapy for lung cancer. Thoracic Cancer 2012 May;3(2):109-116.
  121. Nichols Jr. RC, Huh S, Henderson RH, Li Z, Flampouri S, D'Agostino HJ, Cury JD, Pham DC, Mendenhall NP, Hoppe BS. Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparison. Thoracic Cancer 2012 May;3(2):169-174.
  122. Shi W, Nichols RC, Flampouri S, His W, Li Z, Henderson RH, Mendenhall NP, Hoppe B. Tumour Shrinkage during Proton-based Chemoradiation forNon–small-cell Lung Cancer May Necessitate Adaptive Replanning during Treatment. Hong Kong J Radiol. 2011;14:190-4
  123. Figura N, Flampouri S, Hopper K, Marcus R, Mendenhall NP, Hoppe BS.  Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin Lymphoma.  JAYAO 2011 1(2): 103-6
  124. Shi W, Nichols RC, Flampouri S, Hsi W, Li Z, Henderson RH, Mendenhall NP, Hoppe BS.  Tumor Shrinkage during Proton-based Chemoradiation for Non-small-cell Lung Cancer May Necessitate Adaptive Replanning during Treatment.  Hong Kong J Radiol. 2011;14:190-4
  125. Nichols RC, Huh SH, Hoppe BS, Henderson RH, Li Z, Flampouri S, D'Agostino HJ, Cury JD, Pham DC, Mendenhall NP. Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer. Technol Cancer Res Treat. 2011 Aug;10(4):317-22. PubMed PMID: 21728388.
  126. Jin H, Palta JR, Kim YH, Kim S. Application of a novel dose-uncertainty model for dose-uncertainty analysis in prostate intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):920-8. Epub 2010 Jun 30. PubMed PMID: 20584579.
  127. Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell LK.  Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys. 2010 Aug 15;11(4):3255. PubMed PMID: 21081882.
  128. Chvetsov AV, Paige SL. The influence of CT image noise on proton range calculation in radiotherapy planning. Phys Med Biol. 2010 Mar 21;55(6):N141-9. Epub 2010 Feb 24. PubMed PMID: 20182006.
  129. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. Epub 2009 Apr 20. PubMed PMID: 19386423.
  130. Chvetsov AV, Dong L, Palta JR, Amdur RJ. Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):595-602. PubMed PMID: 19596173.
  131. Hsi WC, Indelicato DJ, Vargas C, Duvvuri S, Li Z, Palta J. In vivo verification of proton beam path by using post-treatment PET/CT imaging. Med Phys. 2009 Sep;36(9):4136-46. PubMed PMID: 19810487.
  132. Hsi WC, Moyers MF, Nichiporov D, Anferov V, Wolanski M, Allgower CE, Farr JB, Mascia AE, Schreuder AN. Energy spectrum control for modulated proton beams. Med Phys. 2009 Jun;36(6):2297-308. PubMed PMID: 19610318; PubMed Central PMCID: PMC2832068.
  133. Vargas C, Mahajan C, Fryer A, Indelicato D, Henderson RH, McKenzie C, Horne D, Chellini A, Lawlor P, Li Z, Oliver K, Keole S. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1110-6. PubMed PMID: 17967305.

Select research demonstrating the benefits of proton therapy for:

Prostate Cancer

Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer

Proton therapy for prostate cancer: the initial Loma Linda University experience

Quality of life and satisfaction with outcome among prostate-cancer survivors

Head and Neck

Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique